Vaccitech plc VACC NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • GB • USD

Vaccitech plc (VACC) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 3 Buy, 1 Hold.

VACC Analyst Ratings

Buy

Ratings

3 Buy

1 Hold

Based on 4 analysts giving stock ratings to Vaccitech plc in the past 3 months

Rating breakdown

Buy

3 75%

Hold

1 25%

75%

Buy

3 analysts

25%

Hold

1 analysts

Sell

0 analysts

People Also View

RVMD

Revolution Medicines, Inc.

$147.01

+7.86%

EWTX

Edgewise Therapeutics, Inc.

$33.16

-2.01%

STOK

Stoke Therapeutics, Inc.

$35.86

+2.31%

TYRA

Tyra Biosciences, Inc.

$35.27

-0.98%

CGEM

Cullinan Oncology, Inc.

$14.35

+0.70%

DSGN

Design Therapeutics, Inc.

$12.64

+2.35%

CTMX

CytomX Therapeutics, Inc.

$4.54

+3.42%

ASMB

Assembly Biosciences, Inc.

$29.44

+0.68%

Vaccitech plc VACC NASDAQ

VACC Analyst Ratings

People Also View

Get Undervalued Stock Alerts